You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 3, March 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity

P. C. Baas, H. Schraffordt Koops, H. J. Hoekstra, J. J. van Bruggen, L. T. van der Weele and J. Oldhoff
Division of Surgical Oncology, Groningen, University Hospital, The Netherlands.

Groin dissection was performed in 151 consecutive patients from 1970 to 1984. Groin dissections were therapeutic in 138 cases (91%) and elective in 13 (9%). One hundred forty-three patients (95%) underwent an ilioinguinal node dissection, while eight (5%) were treated with an inguinal node dissection. In 88 patients, the groin dissection was combined with isolated regional perfusion. Primary wound closure was performed in 140 patients (93%). There was no 30-day postoperative mortality. Complications included temporary seroma (26 [17%] of 151 patients), wound infection (14 patients [9%]), wound necrosis (five patients [3%]), and edema (30 patients [20%]). Residual inguinal node metastases after groin dissection did not occur. Morbidity of groin dissection did not increase when the groin dissection was combined with isolated regional perfusion. Quantification of the degree of edema in 66 patients revealed functional limitation due to edema in three patients (4.5%). This technique of groin dissection gives good results with minimal functional morbidity of the affected leg.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Do Micromorphometric Features of Metastatic Deposits Within Sentinel Nodes Predict Nonsentinel Lymph Node Involvement in Melanoma?
Frankel et al.
Ann. Surg. Oncol. 2008;15:2403-2411.
ABSTRACT | FULL TEXT  

Complete Lymph Node Dissection for Sentinel Node-Positive Melanoma: Assessment of Practice Patterns in the United States
Bilimoria et al.
Ann. Surg. Oncol. 2008;15:1566-1576.
ABSTRACT | FULL TEXT  

Surgical management of metastatic inguinal lymphadenopathy: The term deep inguinal nodes should be abandoned
Gibson et al.
BMJ 2005;330:538-539.
FULL TEXT  

Deep Infection After Ilioinguinal Node Dissection: Vacuum-Assisted Closure Therapy?
Steenvoorde et al.
INT J LOW EXTREM WOUNDS 2004;3:223-226.
ABSTRACT  

A Critical Assessment of Adjuvant Radiotherapy for Inguinal Lymph Node Metastases from Melanoma
Ballo et al.
Ann. Surg. Oncol. 2004;11:1079-1084.
ABSTRACT | FULL TEXT  

Complications Associated With Sentinel Lymph Node Biopsy for Melanoma
Wrightson et al.
Ann. Surg. Oncol. 2003;10:676-680.
ABSTRACT | FULL TEXT  

Risk Factors for Nodal Recurrence After Lymphadenectomy for Melanoma
Pidhorecky et al.
Ann. Surg. Oncol. 2001;8:109-115.
ABSTRACT | FULL TEXT  

Cutaneous Melanoma Metastases
Lee et al.
NEJM 1998;338:922-923.
FULL TEXT  

Extraperitoneal Laparoscopically Assisted Ilioinguinal Lymphadenectomy for Treatment of Malignant Melanoma
Trias et al.
Arch Surg 1998;133:272-275.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.